Expression and clinical significance of CMTM1 in hepatocellular carcinoma
CKLF Like Marvel Transmembrane Domain Containing 1 (CMTM1) plays a role in breast cancer and lung cancer, but studies on the occurrence and development of CMTM1 in hepatocellular carcinoma (HCC) have not been reported.
Main Authors: | Song Xin, Zhang Shidong, Tian Run, Zheng Chuanjun, Xu Yuge, Wang Tianxian, Bei Chunhua, Zhang Huixia, He Xiao, Zhu Xiaonian, Tan Shengkui |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-01-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2021-0221 |
Similar Items
-
Down-Regulated CMTM2 Promotes Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
by: Zhang S, et al.
Published: (2020-06-01) -
CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells
by: Xiaoting Huang, et al.
Published: (2021-03-01) -
CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients
by: Xin Li, et al.
Published: (2020-08-01) -
Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers
by: Hiroto Takeuchi, et al.
Published: (2020-06-01) -
Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment
by: Yanbin Zhao, et al.
Published: (2021-01-01)